Impact of number of lifetime antiseizure medications on 12-month effectiveness, quality of life and tolerability outcomes of adjunctive brivaracetam in patients with focal seizures: Post-hoc analysis of a real-world European study

被引：0
|
作者：
Leach, J. [1 ]
Kelemen, A. [2 ]
Doherty, C. [3 ,4 ]
Schulz, A. -L. [5 ]
Brock, F. [6 ]
Leunikava, I.
Bourikas, D. [7 ]
Steinhoff, B. [8 ]
机构：
[1] Univ Glasgow, Sch Med, Glasgow, Lanark, Scotland
[2] Natl Inst Clin Neurosci, Budapest, Hungary
[3] Trinity Coll Dublin, Dublin, Ireland
[4] RCSI, FutureNeuro, SFI Res Ctr, Dublin, Ireland
[5] UCB Pharma, Monheim, Germany
[6] UCB Pharma, Slough, Berks, England
[7] UCB Pharma, Alimos, Greece
[8] Kork Epilepsy Ctr, Kehl, Germany
来源：
EPILEPSIA | 2022年 / 63卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
309
引用
收藏
页码：64 / 64
页数：1
相关论文
共 31 条
  • [1] Effect of Number of Previous Antiseizure Medications on Efficacy and Tolerability of Adjunctive Brivaracetam for Uncontrolled Focal Seizures: Post Hoc Analysis
    Sang-Kun Lee
    Kyoung Heo
    Sung-Eun Kim
    Sang-Ahm Lee
    Sami Elmoufti
    Cédric Laloyaux
    Boeun Hur
    Advances in Therapy, 2021, 38 : 4082 - 4099
  • [2] Effect of Number of Previous Antiseizure Medications on Efficacy and Tolerability of Adjunctive Brivaracetam for Uncontrolled Focal Seizures: Post Hoc Analysis
    Lee, Sang-Kun
    Heo, Kyoung
    Kim, Sung-Eun
    Lee, Sang-Ahm
    Elmoufti, Sami
    Laloyaux, Cedric
    Hur, Boeun
    ADVANCES IN THERAPY, 2021, 38 (07) : 4082 - 4099
  • [3] Effectiveness and Tolerability of Brivaracetam by Reason for Initiation in Adults with Focal Seizures: Post-hoc Analysis of a Real-world, US Study
    Henninger, Heidi
    Sperling, Michael R.
    Altalib, Hamada Hamid
    Dave, Hina
    Gelfand, Michael
    Porter, Roger J.
    Martin, Melinda S.
    Elmoufti, Sami
    Schulz, Anne-Liv
    Dongre, Prashant
    French, Jacqueline A.
    NEUROLOGY, 2022, 98 (18)
  • [4] Effectiveness and Tolerability of Brivaracetam by Number of Lifetime Antiseizure Medications in Adults with Focal Onset Seizures: Pooled Data From Two Real-world Studies
    Martin, Melinda S.
    Bourikas, Dimitrios
    Brock, Fiona
    Dongre, Prashant
    Elmoufti, Sami
    Leunikava, Iryna
    Little, Allison
    Schulz, Anne-Liv
    NEUROLOGY, 2023, 100 (17)
  • [5] Retention, efficacy, tolerability, and quality of life during long-term adjunctive brivaracetam treatment by number of lifetime antiseizure medications: A post hoc analysis of phase 3 trials in adults with focal seizures
    Brandt, Christian
    Dimova, Svetlana
    Elmoufti, Sami
    Laloyaux, Cedric
    Nondonfaz, Xavier
    Klein, Pavel
    EPILEPSY & BEHAVIOR, 2023, 138
  • [6] 12-Month Effectiveness and Tolerability of Brivaracetam in the Real-World: The International EXPERIENCE Pooled Analysis
    Villanueva, Vicente
    D'Souza, Wendyl
    Faught, Edward
    Klein, Pavel
    Reuber, Markus
    Rosenow, Felix
    Salas-Puig, Javier
    Insuga, Victor Soto
    Strzelczyk, Adam
    Szaflarski, Jerzy P.
    Besson, Herve
    Daniels, Tony
    Floricel, Florin
    Laloyaux, Cedric
    Sendersky, Veronica
    Zhou, Sophia
    Steinhoff, Bernhard J.
    NEUROLOGY, 2023, 100 (17)
  • [7] 12-Month effectiveness and tolerability of brivaracetam in patients with epilepsy switching from levetiracetam vs other antiseizure medications in the real-world: subgroup data from the international EXPERIENCE pooled analysis
    Steinhoff, B. J.
    D'Souza, W.
    Faught, E.
    Klein, P.
    Reuber, M.
    Rosenow, F.
    Salas-Puig, J.
    Insuga, V. Soto
    Strzelczyk, A.
    Szaflarski, J. P.
    Besson, H.
    Bourikas, D.
    Daniels, T.
    Floricel, F.
    Friesen, D.
    Laloyaux, C.
    Sendersky, V.
    Villanueva, V.
    EPILEPSIA, 2023, 64 : 274 - 274
  • [8] Treatment outcomes by reason for adjunctive brivaracetam initiation in a real-life setting: Post-hoc analysis of a European study
    Steinhoff, B.
    Kelemen, A.
    Doherty, C.
    Schulz, A. -L.
    Brock, F.
    Leunikava, I.
    Bourikas, D.
    Leach, J.
    EPILEPSIA, 2022, 63 : 116 - 116
  • [9] Effectiveness During 12-Month Adjunctive Brivaracetam Treatment in Patients with Focal-Onset Seizures in a Real-Life Setting: A Prospective, Observational Study in Europe
    Steinhoff, Bernhard J.
    Christensen, Jakob
    Doherty, Colin P.
    Majoie, Marian
    Schulz, Anne-Liv
    Brock, Fiona
    Bourikas, Dimitrios
    Leunikava, Iryna
    Kelemen, Anna
    Rubio-Nazabal, Eduardo
    NEUROLOGY AND THERAPY, 2025, 14 (02) : 627 - 642
  • [10] Treatment satisfaction, work productivity, and quality of life under adjunctive brivaracetam in earlier treatment lines in adults with focal- onset seizures: 12-month real-world data from BRITOBA
    Winter, Y.
    Boero, G.
    Didato, G.
    Didelot, A.
    Hirsch, E.
    Kuehn, F.
    Navarro, V.
    Rehel, B.
    Schulz, A-L
    Leunikava, I.
    EPILEPSIA, 2024, 65 : 178 - 179
1234